Bliss GVS Pharma shareholding pattern

BLISSGVS

HealthcareSmall

174.63

5.29 (3.12%)
Last updated on 18 Aug, 2025 | 15:47 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Bliss GVS Pharma Shareholding Pattern

  • 2016-17
  • 2017-18
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2024-25
  • 2025-26
  • 2023-24
Total Promoters
Segment
Percent

Total Promoters

35.1%

Mutual Fund

0%

Insurance

6.55%

Foreign Institutional Investors

13.51%

Domestic Institutional Investors

0%

Retail

44.84%

Others

0%

Total Promoters
MAR '24
34.97%
JUN '24
34.9%
SEP '24
34.82%
DEC '24
35.1%

Bliss GVS Pharma FAQs

As of 08-2025, the promoter shareholding in Bliss GVS Pharma stands at 35.44% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Bliss GVS Pharma is 12.65% and 0% respectively.

The retail shareholding of the Bliss GVS Pharma is 45.36%.

Changes in shareholding patterns of Bliss GVS Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Bliss GVS Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.